enzalutamide sandoz
sandoz d.d. - enzalutamidas - plėvele dengtos tabletės - 80 mg - enzalutamide
sevorane
abbvie sia - sevofluranas - įkvepiamieji garai (skystis) - 250 ml - sevoflurane
azithromycin teva
teva pharma b.v. - azitromicinas - disperguojamosios tabletės - 250 mg; 500 mg - azithromycin
diltiazem lannacher
g.l. pharma gmbh - diltiazemas - pailginto atpalaidavimo tabletės - 180 mg; 90 mg - diltiazem
zylumit
rivopharm ltd. - azitromicinas - plėvele dengtos tabletės - 500 mg - azithromycin
azithromycin sandoz
sandoz gmbh - azitromicinas - plėvele dengtos tabletės - 500 mg - azithromycin
xenleta
nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibacterials sisteminio naudojimo, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. reikėtų atsižvelgti į oficialius nurodymus, kaip tinkamai naudoti antibakterinių veiksnių.
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antinavikiniai vaistai - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
jaypirca
eli lilly nederland b.v. - pirtobrutinib - limfoma, mantle-cell - baltymų kinazės inhibitoriai - treatment of mantle cell lymphoma (mcl).
sevoflurane piramal
piramal critical care b.v. - sevofluranas - įkvepiamieji garai (skystis) - 100 % - sevoflurane